Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI

NCT05014516 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2025-08-01

No results posted yet for this study

Summary

In this study the Investigators aim to deploy UTE and HP 129Xe MRI for structural and functional evaluation of persistent lung abnormalities in COVID-19 survivors.

Conditions

  • COVID-19 Respiratory Infection

Interventions

DRUG

129Xenon gas

Observational

Sponsors & Collaborators

  • Western University

    collaborator OTHER
  • The Hospital for Sick Children

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-05
Primary Completion
2024-03-20
Completion
2024-03-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05014516 on ClinicalTrials.gov